Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women

NCT00683800 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2186

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms

Interventions

DRUG: desvenlafaxine succinate (DVS) SR
DRUG: Placebo

Sponsor

Pfizer